BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
US Department of Justice
Teva
Federal Trade Commission
Julphar
Dow
Harvard Business School
Chubb
Healthtrust
Colorcon

Generated: January 21, 2018

DrugPatentWatch Database Preview

NEOMYCIN Drug Profile

« Back to Dashboard

When do Neomycin patents expire, and what generic alternatives are available?

Neomycin is a drug marketed by Pharmafair, Watson Labs, X Gen Pharms, Akorn, Bausch And Lomb, Perrigo Co Tennessee, Alcon Pharms Ltd, Amring Pharms, Ipharm, Sandoz Inc, Breckenridge Pharm, Bristol Myers Squibb, Lannett, Lannett Holdings Inc, Lilly, Roxane, Sandoz, Teva, Fougera, and Pharmaderm. and is included in forty-two NDAs.

The generic ingredient in NEOMYCIN is neomycin sulfate; triamcinolone acetonide. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.
Summary for NEOMYCIN
Drug patent expirations by year for NEOMYCIN

US Patents and Regulatory Information for NEOMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmaderm NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE neomycin sulfate; triamcinolone acetonide OINTMENT;TOPICAL 062607-001 May 23, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bausch And Lomb NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate; neomycin sulfate SOLUTION/DROPS;OPHTHALMIC 064055-001 Oct 30, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roxane NEOMYCIN SULFATE neomycin sulfate TABLET;ORAL 062173-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmafair NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN gramicidin; neomycin sulfate; polymyxin b sulfate SOLUTION/DROPS;OPHTHALMIC 062383-001 Aug 31, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz NEOMYCIN SULFATE neomycin sulfate TABLET;ORAL 061586-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmafair NEOMYCIN & POLYMYXIN B SULFATES & BACITRACIN ZINC & HYDROCORTISONE bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate OINTMENT;TOPICAL 062381-001 Sep 6, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE hydrocortisone; neomycin sulfate; polymyxin b sulfate SUSPENSION/DROPS;OPHTHALMIC 062874-001 May 11, 1988 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb NEOMYCIN SULFATE neomycin sulfate TABLET;ORAL 060365-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmaderm NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE neomycin sulfate; triamcinolone acetonide CREAM;TOPICAL 062595-001 Jul 21, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Perrigo Co Tennessee NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 060764-002 Approved Prior to Jan 1, 1982 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Healthtrust
Boehringer Ingelheim
Johnson and Johnson
Queensland Health
Dow
US Army
UBS
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot